无缝管理理念干预对冠心病患者的影响

Influence of seamless management concept intervention on patients with coronary heart disease

目的:研究无缝管理理念干预对冠心病(CHD)患者的影响。方法:于我院治疗的98例CHD患者,按照随机数字表法被均分为常规干预组(常规治疗基础上行常规随访管理)和无缝管理组(常规治疗基础上行无缝管理干预),两组均干预一年。比较两组一般临床资料、干预前后总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、同型半胱氨酸(Hcy)水平及随访1年期间主要不良心血管事件(MACE)发生率。结果:与常规干预组比较,干预后,无缝管理组TC[(3.39±0.54)mmol/L比(2.95±0.59)mmol/L]、LDL-C[(2.02±0.54)mmol/L比(1.74±0.53)mmol/L]、Hcy水平[(15.69±5.09)mmol/L比(13.41±4.96)mmol/L]均显著降低,HDL-C水平[(1.33±0.40)mmol/L比(1.57±0.27)mmol/L]显著升高(P<0.05或<0.01)。无缝管理组随访1年期间MACE发生率显著低于常规干预组(8.16%比26.53%,P=0.014)。结论:无缝管理理念干预能显著改善冠心病患者血脂水平,降低同型半胱氨酸水平及主要不良心血管事件发生率。

Objective:To study influence of seamless management concept intervention on patients with coronary heart disease(CHD).Methods:A total of 98 CHD patients treated in our hospital were randomly and equally divided into routine intervention group(received routine follow-up management based on routine treatment)and seamless management group(received seamless management intervention based on routine treatment)according to random number table method.Both groups were intervened for one year.General clinical data,levels of total cholesterol(TC),triglyceride(TG),high density lipoprotein cholesterol(HDL-C),low density lipoprotein cholesterol(LDL-C)and homocysteine(Hcy)before and after intervention and incidence rate of major adverse cardiovascular events(MACE)within one-year follow-up were compared between two groups.Results:Compared with routine intervention group,after intervention,there were significant reductions in levels of TC[(3.39±0.54)mmol/L vs.(2.95±0.59)mmol/L],LDL-C[(2.02±0.54)mmol/L vs.(1.74±0.53)mmol/L]and Hcy[(15.69±5.09)mmol/L vs.(13.41±4.96)mmol/L],and significant rise in HDL-C level[(1.33±0.40)mmol/L vs.(1.57±0.27)mmol/L]in seamless management group(P<0.05 or<0.01).Incidence rate of MACE during one-year follow-up in seamless management group was significantly lower than that of routine intervention group(8.16%vs.26.53%,P=0.014).Conclusion:Seamless management concept intervention can significantly improve blood lipid levels,reduce homocysteine level and incidence rate of major adverse cardiovascular events in patients with coronary heart disease.